INSMED Inc
For the period ended Sep 30, 2025. Filed Oct 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 30, 2025
INSM$116.10+1.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Financial Statements Consolidated Balance Sheets as of (unaudited) and
Consolidated Balance Sheets
(in thousands, except par value and share data)
| As of | As of | |
|---|---|---|
| September 30, 2025 | December 31, 2024 | |
| (unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $334,764 | $555,030 |
| Marketable securities | 1,345,222 | 878,796 |
| Accounts receivable | 65,259 | 52,012 |
| Inventory | 120,965 | 98,578 |
| Prepaid expenses and other current assets | 65,597 | 37,245 |
| Total current assets | 1,931,807 | 1,621,661 |
| Fixed assets, net | 89,671 | 80,052 |
| Finance lease right-of-use assets | 16,239 | 18,273 |
| Operating lease right-of-use assets | 10,708 | 17,257 |
| Intangibles, net | 84,588 | 58,652 |
| Goodwill | 136,110 | 136,110 |
| Other assets | 91,613 | 93,226 |
| Total assets | $2,360,736 | $2,025,231 |
| Liabilities and shareholders’ equity | ||
| Current liabilities: | ||
| Accounts payable and accrued liabilities | $409,835 | $285,209 |
| Finance lease liabilities | 3,246 | 2,961 |
| Operating lease liabilities | 4,133 | 9,358 |
| Total current liabilities | 417,214 | 297,528 |
| Debt, long-term | 539,719 | 1,103,382 |
| Royalty financing agreement | 163,854 | 161,067 |
| Contingent consideration | 259,600 | 144,200 |
| Finance lease liabilities, long-term | 21,595 | 24,064 |
| Operating lease liabilities, long-term | 7,588 | 9,112 |
| Other long-term liabilities | 5,595 | 499 |
| Total liabilities | 1,415,165 | 1,739,852 |
| Shareholders’ equity: | ||
| Common stock, $0.01 par value; 500,000,000 authorized shares, 212,583,015 and 179,382,635 issued and outstanding shares at September 30, 2025 and December 31, 2024, respectively | 2,126 | 1,794 |
| Additional paid-in capital | 6,249,654 | 4,645,791 |
| Accumulated deficit | (5,308,207) | (4,359,917) |
| Accumulated other comprehensive gain (loss) | 1,998 | (2,289) |
| Total shareholders’ equity | 945,571 | 285,379 |
| Total liabilities and shareholders’ equity | $2,360,736 | $2,025,231 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.